Breast Cancers
GI Cancers
Gynecologic Cancer
Immunology News
Multiple Myeloma
Head and Neck
Lung Cancers
Prostate Cancer
Kidney Cancer
Precision Medicine
Supportive Care
Soft Tissue Sarcoma
Giants Cancer Care

Latest News & Updates

Latest Articles
Enzalutamide (Xtandi) pricing heightens the likelihood of pre-authorization requirements and cost-sharing arrangements that may be financially burdensome, ruinous, or simply impossible to meet.
PUBLISHED: May 01, 2016
Bone metastases in metastatic castration-resistant prostate cancer can invade a range of sites in the skeleton where they precipitate a spectrum of pathological processes that increase morbidity, negatively affect quality of life, and decrease survival.
PUBLISHED: April 30, 2016
The Committee for Medicinal Products for Human Use has recommended the first-line approval of bevacizumab (Avastin) in combination with erlotinib (Tarceva) for patients with advanced or metastatic EGFR-mutant non–small cell lung cancer.
PUBLISHED: April 29, 2016
Obinutuzumab (Gazyva) has received a positive recommendation from the EMA’s Committee for Medicinal Products for Human Use for use in combination with bendamustine as a treatment for patients with follicular lymphoma who previously received chemotherapy.
PUBLISHED: April 29, 2016
The Committee for Medicinal Products for Human Use has recommended the frontline approval for ibrutinib (Imbruvica) as a single-agent for patients with chronic lymphocytic leukemia.
PUBLISHED: April 29, 2016
Latest Peer Exchange Discussions
David P. Steensma, MD, provides insight on best practices for preventing and diagnosing iron overload. View Now
The panelists, Richard Kim, MD; Charles S. Fuchs, MD; and Daniel G. Haller, MD, FACP, FRCP, outline the usefulness of a PI3K mutation as a biomarker, and the potential benefits of administering aspirin in individuals with colorectal cancer. View Now
The panelists, Johanna Bendell, MD; Caio Rocha Lima, MD; Thomas A. Abrams MD; and George P. Kim, MD, describe several investigational vaccines in pancreatic cancer. View Now
The panelists, John L. Marshall, MD; Tanios Bekaii-Saab, MD; Johanna Bendell, MD; Richard Kim, MD; and Charles S. Fuchs, MD, describe dosing strategies for the ‘tyrosine kinase inhibitor, regorafenib, and its impact on the management of advanced colorectal cancer. View Now
Online CME Activities
Free CME from PER
Cancer Summaries and Commentaries™: 2016 Conference Coverage: Advances in the Treatment of Genitourinary Cancers
Community Practice Connections™: 12th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
Advances in the Treatment of Metastatic Colorectal Cancer
Renal Cell Carcinoma: Recent Advances, New Questions